AtriCure Market Risk Adjusted Performance
| ATRC Stock | | | USD 29.86 0.68 2.33% |
This technical indicator view for Market Risk Adjusted Performance organizes signals for AtriCure and comparable instruments. Availability can vary by instrument;
Equity Screeners offers additional screening access. AtriCure has market cap of 1.45 B, P/E of 33.47, operating margin of 1.77%. See
Trending Equities for portfolio-level analysis. This suggests a position in AtriCure within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
Our
How to Buy AtriCure Stock guide explains the steps to invest in AtriCure stock.
AtriCure has current Market Risk Adjusted Performance of
-0.25.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.25 | |
| ER[a] | = | Expected return on investing in AtriCure |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
AtriCure Market Risk Adjusted Performance Peers Comparison
AtriCure Market Risk Adjusted Performance Relative To Other Indicators
AtriCure is rated
below average. in market risk adjusted performance category among its top compatitors. It is currently under evaluation. in maximum drawdown category among its top compatitors .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.